-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 23, Yiling Pharmaceuticals stated that it received the "Drug Supplementary Application Approval Notice" for metoprolol tartrate tablets approved and issued by the National Medical Products Administration, and the drug passed the generic drug quality and efficacy consistency evaluation
Metoprolol tartrate is a commonly used selective β-receptor blocker in clinical practice.
Metoprolol tartrate tablets are a category A variety of the National Medical Insurance Catalog (2020 edition) and a variety of the National Essential Medicines Catalog (2018 edition)
According to relevant national policies and regulations, appropriate support will be provided in terms of medical insurance payment for drug varieties that have passed the consistency evaluation; medical institutions should give priority to procurement and give priority to selection in the clinic; at the same time, products that have passed the consistency evaluation will have the ability to participate in the national drug centralized procurement Qualifications